Study identifies PLA2G7 suppression in neural stem cells as a driver of cognitive enhancement in aged mice

The discovery of PLA2G7 as a negative regulator of dentate gyrus synaptic function reveals a novel target for reversing age-related cognitive decline through neural stem cell lipid modulation.

A study published in Nature Aging by Wu and colleagues has identified PLA2G7, a secreted lipid-metabolizing enzyme, as a negative regulator of inhibitory synapses in the dentate gyrus of the brain.

The researchers demonstrated that genetic or experimental suppression of PLA2G7 in neural stem cells enhances synaptic transmission.

The suppression of this enzyme led to measurable improvements in the cognitive performance of aged mouse models.

Inhibitory circuit dysfunction in the hippocampus is a well-established driver of cognitive decline during aging.

By isolating the role of PLA2G7 to neural stem cells, the study highlights a highly localized metabolic regulator of synaptic plasticity, shifting focus toward niche-specific microenvironments in the aging brain.

Because PLA2G7 is a secreted enzyme, it represents a potentially druggable target for small molecules or monoclonal antibodies designed to cross the blood-brain barrier.

The identification of PLA2G7 introduces a new biological target for therapeutic discovery, which could impact preclinical pipelines focused on cognitive preservation and synaptic restoration.

This finding offers an alternative to traditional, plaque- or aggregate-centric neurodegeneration targets, potentially encouraging early-stage biotechs to explore lipid-metabolizing enzymes in the central nervous system.

Preclinical validation of selective, small-molecule PLA2G7 inhibitors to determine if pharmacological intervention mimics the genetic suppression observed in this study.

Translational research mapping PLA2G7 expression and activity in human neural stem cells and aged brain tissue to confirm the relevance of the pathway in humans.